Diabetes, which occurs due to an increase in the level of blood glucose in the body, can severely affect the various part of the body. Such as nerve damage, heart attack, other heart-related diseases, kidney failure, and most common foot problems. Older diabetics patients are highly at the risk of getting foot deformities as it is the last stage of people with diabetes and mostly found in a more aged population. Thus, foot deformities are the reason for the emerging demand for the diabetic footwear market. Therefore, doctors are highly recommending the use of diabetic footwear for promoting blood circulation in feet, which in turn will fuel the market growth. Diabetic patients often experience foot numbness and cold feet. Early symptoms of the diabetic foot, such as pain, diminished foot sensation, and foot edema, seriously affect the quality of life of patients. Therefore, diabetic shoes are suitable products for patients with diabetes.
The global Diabetic Footwear market expected to grow at 8% CAGR in the forecast period from 2020-2027. The adoption of diabetic footwear in the wake of skin breakage caused due to poor blood circulation in diabetic patients, and this condition can further lead to neuropathy and foot deformities. Thus, diabetic footwears designed in such a manner that are functional soles, provide extra depth pressure for fit free, stretchable upper and non-binding upper and orthotic support that give comfort to the deformities foot of the diabetic patients. Besides, emerging advanced technology has developed the demand for customized and fashionable diabetic footwear for diabetic patients to meet up with the trend. Therefore, it contributes to propelling the market value of the diabetic footwear market. Improper wearing of shoes is a more direct factor. Diabetic footwear should not be too hard, and the fabric recommended to be cotton. When buying shoes for diabetics, one can’t just look at the size, and it suggested to purchase shoes in the afternoon because the feet are relatively large at this time. When choosing shoes, make sure that there is enough space at the front of the shoes.
Additionally, the upper surface of diabetic footwear uses the highest quality cow and sheep leather, which is both comfortable and soft. The insole uses a unique formula of medical EVA special decompression material, which can disperse the stress points of the feet and effectively reduce the pressure. The sole uses high-quality hair foam has the function of wear-resisting, skid-resistance, and lightweight. Also, the use of the nano-silver antibacterial agent in the shoes can effectively inhibit the generation and reproduction of harmful bacteria in the shoes. Thus, the purpose of decompression and antibacterial and effective prevention and relief of diabetic foot achieved.
For the prevention of foot ulcers in diabetic patients, the guideline explicitly states that wearing diabetic shoes customized or used with foot orthosis is the key to preventing foot ulcers in diabetic patients. Moreover, these footwear helps in reducing the pain and provide relief from flat foot pain. Thus, diabetic footwear adoption increased due to awareness among the patients regarding the advantages of diabetic footwear.
The increase in cardiovascular diseases and emerging populations with people with diabetes has impacted positively on the market value of diabetic footwear in the market. Also, the increasing technological advancement and other health facilities have influenced the market share of footwear.
Based on the distribution channel, the global diabetic footwear market segmented into Online Platform, Specialty Store, Footwear Store, Others. The specialty stores and pharma shops are the offline stores that are the primary channel for the consumer for the purchase of the diabetic footwear market. Due to an increasing elderly population who are majorly diabetic patients and they prefer offline stores more as they can quickly try the footwear and then buy it. On the other hand, online stores are leading the market based on original payment features, cash on delivery, benefits, and various discount, which will bolster its market share in the forecast period from 2020-2027.
Based on the Type, the global diabetic footwear market classified into Shoes, Sandals, and Slippers. The shoe segment among the diabetic footwear segment will fuel the market share of the global diabetic footwear market. As diabetes is a genetic disease and can occur to anybody and also, a large number of populations are office-going. Therefore, these shoes can be paired with formal attire, and it also helps in preventing feet injuries and fungus infection. Moreover, older people who generally stay at home prefer slippers for wearing them from day today. Thus, the slippers market will also show lucrative growth than the shoe market in the forecast period from 2020-2027.
Based on the end-uses channel, the global diabetic footwear market bifurcated into Men and Women. The women’s footwear segment is dominating the market share and will continue to propel its growth in the forecast period from 2020-2027. In the wake of, large no. of office going women population. Moreover, different color, design help in emerging the demand for the global diabetic footwear market.
Based on geography, the global diabetic footwear market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. The North America region has emerged the highest market value for the diabetic footwear market and will fuel the market growth in the forecast period from 2020-2027. Owing to a boost in the number of diabetic patients, cardiovascular diseases, and the obesity rate. Thus, North America will propel the market for diabetic footwear worldwide. Moreover, the Asia Pacific region will also bolster the demand for the diabetic footwear market due to the rising elderly population and increasing diabetic risk. With increasing, disposable income people can easily afford footwear to reduce the pain in the foot.
Companies such as Podartis Srl, DJO Global Inc., Aetrex Worldwide, Inc., Dr. Zen Products, Inc., Orthofeet Inc., Propet USA, Inc., I-Runner, Pilgrim shoes, Finn Comfort, and Drew Shoes and others are the key players in the global diabetic footwear market.
|Market size value in 2020||USD 7.56 billion|
|Revenue forecast in 2027||USD 11.23 billion|
|Growth Rate||CAGR of 8.25% from 2020 to 2027|
|Forecast period||2021 – 2027|
|Region covered||North America, Europe, Asia-Pacific, South America, and Middle East & Africa|
|Key companies Profiled||Dr. Zen Products, Inc., Orthofeet Inc., Podartis Srl, I-Runner, Pilgrim shoes,|
Finn Comfort, DJO Global Inc., Aetrex Worldwide, Inc., Propet USA, Inc.,
and Drew Shoes and others
By Distribution Channel
The diabetic footwear market is valued at USD 7.56 billion in 2020 and will reach USD 11.23 billion by 2027.
The diabetic footwear market will grow at a compound annual growth rate of 8.2% from 2021 to 2027.
Men and Women are the end-users of the diabetic footwear market products.
Prevention of foot ulcers in diabetic patients, increasing diabetes and cardiovascular diseases are the growth drivers of the diabetic footwear market.
Dr. Zen Products, Inc., Orthofeet Inc., Podartis Srl, I-Runner, Pilgrim shoes, Finn Comfort, DJO Global Inc., Aetrex Worldwide, Inc., Propet USA, Inc., and Drew Shoes and others are the key players of the diabetic footwear market.